Suvretta Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.8M | Buy |
2,278,000
+253,500
| +13% | +$9.22M | 2.5% | 7 |
|
|
2025
Q1 | $73.3M | Buy |
2,024,500
+873,186
| +76% | +$31.6M | 2.72% | 9 |
|
|
2024
Q4 | $48.4M | Hold |
1,151,314
| – | – | 1.65% | 17 |
|
|
2024
Q3 | $64M | Sell |
1,151,314
-910,112
| -44% | -$50.6M | 2.05% | 11 |
|
|
2024
Q2 | $84.7M | Buy |
2,061,426
+384,615
| +23% | +$15.8M | 3.11% | 6 |
|
|
2024
Q1 | $78.3M | Sell |
1,676,811
-449,495
| -21% | -$21M | 2.91% | 5 |
|
|
2023
Q4 | $102M | Buy |
2,126,306
+1,446,847
| +213% | +$69.2M | 4.6% | 4 |
|
|
2023
Q3 | $24.2M | Buy |
679,459
+137,979
| +25% | +$4.92M | 1.31% | 25 |
|
|
2023
Q2 | $25M | Sell |
541,480
-75,000
| -12% | -$3.46M | 1.34% | 27 |
|
|
2023
Q1 | $24.7M | Sell |
616,480
-200,691
| -25% | -$8.05M | 1.04% | 32 |
|
|
2022
Q4 | $37.9M | Buy |
817,171
+728,231
| +819% | +$33.7M | 1.59% | 26 |
|
|
2022
Q3 | $3.68M | Sell |
88,940
-259,579
| -74% | -$10.7M | 0.15% | 61 |
|
|
2022
Q2 | $20.8M | Sell |
348,519
-176,581
| -34% | -$10.5M | 0.79% | 43 |
|
|
2022
Q1 | $38.1M | Buy |
525,100
+39,858
| +8% | +$2.89M | 1.16% | 33 |
|
|
2021
Q4 | $40.8M | Buy |
+485,242
| New | +$40.8M | 0.79% | 36 |
|